A detailed history of Noesis Capital Mangement Corp transactions in Pfizer Inc stock. As of the latest transaction made, Noesis Capital Mangement Corp holds 15,944 shares of PFE stock, worth $423,472. This represents 0.09% of its overall portfolio holdings.

Number of Shares
15,944
Previous 15,590 2.27%
Holding current value
$423,472
Previous $436 Million 5.78%
% of portfolio
0.09%
Previous 0.1%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $9,805 - $11,112
354 Added 2.27%
15,944 $461 Million
Q2 2024

Aug 05, 2024

BUY
$25.26 - $29.6 $15,206 - $17,819
602 Added 4.02%
15,590 $436 Million
Q1 2024

May 03, 2024

SELL
$25.89 - $29.73 $42,692 - $49,024
-1,649 Reduced 9.91%
14,988 $416 Million
Q4 2023

Feb 06, 2024

BUY
$26.13 - $33.94 $5,226 - $6,788
200 Added 1.22%
16,637 $479 Million
Q2 2023

Jul 31, 2023

SELL
$36.12 - $41.79 $23,658 - $27,372
-655 Reduced 3.83%
16,437 $603 Million
Q1 2023

May 08, 2023

BUY
$39.39 - $51.28 $5,238 - $6,820
133 Added 0.78%
17,092 $697 Million
Q4 2022

Feb 02, 2023

SELL
$41.75 - $54.5 $709 - $926
-17 Reduced 0.1%
16,959 $869 Million
Q3 2022

Nov 01, 2022

SELL
$43.76 - $53.42 $4,288 - $5,235
-98 Reduced 0.57%
16,976 $743 Million
Q2 2022

Jul 29, 2022

SELL
$46.53 - $55.17 $13,959 - $16,551
-300 Reduced 1.73%
17,074 $895,000
Q1 2022

May 05, 2022

SELL
$45.75 - $56.69 $50,096 - $62,075
-1,095 Reduced 5.93%
17,374 $899,000
Q4 2021

Feb 03, 2022

SELL
$41.32 - $61.25 $26,072 - $38,648
-631 Reduced 3.3%
18,469 $1.09 Million
Q3 2021

Nov 04, 2021

SELL
$39.25 - $50.42 $12,167 - $15,630
-310 Reduced 1.6%
19,100 $821,000
Q2 2021

Aug 05, 2021

SELL
$35.91 - $40.68 $3,914 - $4,434
-109 Reduced 0.56%
19,410 $760,000
Q1 2021

May 06, 2021

SELL
$33.49 - $37.77 $15,070 - $16,996
-450 Reduced 2.25%
19,519 $707,000
Q4 2020

Feb 04, 2021

BUY
$33.47 - $42.56 $2,844 - $3,617
85 Added 0.43%
19,969 $735,000
Q3 2020

Nov 05, 2020

SELL
$31.75 - $37.25 $28,352 - $33,264
-893 Reduced 4.3%
19,884 $692,000
Q2 2020

Aug 07, 2020

SELL
$30.12 - $36.54 $25,300 - $30,693
-840 Reduced 3.89%
20,777 $644,000
Q1 2020

May 06, 2020

BUY
$27.03 - $38.62 $8,109 - $11,586
300 Added 1.41%
21,617 $669,000
Q4 2019

Feb 07, 2020

BUY
$32.92 - $37.36 $3,588 - $4,072
109 Added 0.51%
21,317 $835,000
Q3 2019

Nov 05, 2019

SELL
$32.49 - $42.13 $21,118 - $27,384
-650 Reduced 2.97%
21,208 $722,000
Q2 2019

Aug 06, 2019

SELL
$36.98 - $41.52 $113,972 - $127,964
-3,082 Reduced 12.36%
21,858 $0
Q1 2019

May 09, 2019

BUY
$37.5 - $41.2 $22,200 - $24,390
592 Added 2.43%
24,940 $0
Q4 2018

Feb 08, 2019

SELL
$38.47 - $43.86 $1,077 - $1,228
-28 Reduced 0.11%
24,348 $1.06 Million
Q3 2018

Nov 15, 2018

SELL
$34.47 - $41.81 $92,310 - $111,967
-2,678 Reduced 9.9%
24,376 $1.07 Million
Q2 2018

Aug 13, 2018

SELL
$32.98 - $35.16 $84,164 - $89,728
-2,552 Reduced 8.62%
27,054 $982,000
Q1 2018

May 07, 2018

BUY
$31.91 - $37.02 $3,765 - $4,368
118 Added 0.4%
29,606 $1.05 Million
Q4 2017

Feb 14, 2018

SELL
$33.26 - $35.29 $61,664 - $65,427
-1,854 Reduced 5.92%
29,488 $1.07 Million
Q3 2017

Nov 07, 2017

BUY
$31.0 - $34.15 $7,533 - $8,298
243 Added 0.78%
31,342 $1.12 Million
Q2 2017

Aug 10, 2017

BUY
N/A
31,099
31,099 $1.05 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Noesis Capital Mangement Corp Portfolio

Follow Noesis Capital Mangement Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Noesis Capital Mangement Corp, based on Form 13F filings with the SEC.

News

Stay updated on Noesis Capital Mangement Corp with notifications on news.